CLINICAL_TRIALS
trial_result
· 2019-06-17
Clinical Trial Update: Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation [NA]
Summary
A completed clinical trial study investigating genetically determined response to atenolol in patients with persistent atrial fibrillation, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt University Medical Center | Conditions: Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2019-06-17